Average weight loss after 48 weeks Highest dose: around 24% of the starting body weight Mid dose: around 23% Lower dose: around 17% Placebo (dummy injection): around 2% What does 24% actually mean
For additional insight into upcoming treatments and future medication development: GLP-1 Agonists: Pipeline and Emerging Therapies Clinical Uses for GLP-1 Therapies GLP-1 receptor agonists are used across several areas of metabolic medicine
Insulin therapy, including Toujeo, typically causes weight gain
This is a critical, non-negotiable element for any reconstituted solution that will be stored and drawn from multiple times
I got to put my bias, everyone has biases, some that youre aware of
If you are starting a weight loss program that includes semaglutide, your doctor may want to check your INR more frequently during the first few weeks to ensure your levels stay within the target range